Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHamilton, David Lee-
dc.contributor.authorBeall, Craig-
dc.contributor.authorJeromson, Stewart-
dc.contributor.authorChevtzoff, Cyrille-
dc.contributor.authorCuthbertson, Daniel J-
dc.contributor.authorAshford, Michael L J-
dc.description.abstractKnockout of Kv1.3 improves glucose homeostasis and confers resistance to obesity. Additionally, Kv1.3 inhibition enhances glucose uptake. This is thought to occur through calcium release. Kv1.3 inhibition in T-lymphocytes alters mitochondrial membrane potential, and, as many agents that induce Ca2+release or inhibit mitochondrial function activate AMPK, we hypothesised that Kv1.3 inhibition would activate AMPK and increase glucose uptake. We screened cultured muscle with a range of Kv1.3 inhibitors for their ability to alter glucose uptake. Only Psora4 increased glucose uptake in C2C12myotubes. None of the inhibitors had any impact on L6 myotubes. Magratoxin activated AMPK in C2C12myotubes and only Pap1 activated AMPK in the SOL. Kv1.3 inhibitors did not alter cellular respiration, indicating a lack of effect on mitochondrial function. In conclusion, AMPK does not mediate the effects of Kv1.3 inhibitors and they display differential effects in different skeletal muscle cell lines without impairing mitochondrial function.en_UK
dc.relationHamilton DL, Beall C, Jeromson S, Chevtzoff C, Cuthbertson DJ & Ashford MLJ (2014) Kv1.3 inhibitors have differential effects on glucose uptake and AMPK activity in skeletal muscle cell lines and mouse ex vivo skeletal muscle, Journal of Physiological Sciences, 64 (1), pp. 13-20.-
dc.rightsThe publisher does not allow this work to be made publicly available in this Repository. Please use the Request a Copy feature at the foot of the Repository record to request a copy directly from the author. You can only request a copy if you wish to use this work for your own research or private study.-
dc.subjectSkeletal muscleen_UK
dc.subjectGlucose uptakeen_UK
dc.titleKv1.3 inhibitors have differential effects on glucose uptake and AMPK activity in skeletal muscle cell lines and mouse ex vivo skeletal muscleen_UK
dc.typeJournal Articleen_UK
dc.rights.embargoreasonThe publisher does not allow this work to be made publicly available in this Repository therefore there is an embargo on the full text of the work.-
dc.citation.jtitleJournal of Physiological Sciences-
dc.type.statusPublisher version (final published refereed version)-
dc.contributor.affiliationUniversity of Dundee-
dc.contributor.affiliationUniversity of Dundee-
dc.contributor.affiliationAintree University Hospital NHS-
dc.contributor.affiliationUniversity of Dundee-
Appears in Collections:Faculty of Health Sciences and Sport Journal Articles

Files in This Item:
File Description SizeFormat 
Hamilton et al_J Physiol Sci_2013.pdf390.82 kBAdobe PDFUnder Permanent Embargo    Request a copy

This item is protected by original copyright

Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

If you believe that any material held in STORRE infringes copyright, please contact providing details and we will remove the Work from public display in STORRE and investigate your claim.